To download the full report, click here.

This backgrounder looks at the strategies and tactics biopharmaceutical companies have implemented to adapt to evolving trends in the research and development (R&D) process. While the last five years have been among the most productive in history for new drug approvals and innovation, this remarkable progress follows a decade of reduced productivity levels.